Commodity vs specialty business — how to tell the difference

What actually separates a commodity from a specialty?

What separates the two is control over price, and everything else follows from it. A commodity producer’s output is interchangeable with a rival’s, so the buyer decides on price alone and the seller must accept whatever the market clears at. A specialty producer’s output is differentiated enough — by performance, approval, integration, or relationship — that the buyer cannot casually substitute it, which hands the seller room to set price above cost-plus. Two firms can make chemically similar products and sit on opposite sides of this line, because the line is drawn by economics, not by the periodic table.

This matters because the market pays very different multiples for the two. A price-taker’s profit is hostage to input costs, the cycle, and the next low-cost entrant, so it is valued cautiously. A price-maker’s profit is more predictable and more defensible, so it earns a durable premium. The whole point of a value-migration lens is to catch a business moving from the first economics to the second before the multiple catches up.

What are the economic tells of a specialty business?

Specialty economics reveal themselves in a handful of tells that show up in the numbers and in behaviour, not in the marketing. Read them together — any one alone can mislead.

• Price-maker vs price-taker. Ask what happens to selling price when a rival cuts theirs, or when a big customer pushes back. A specialty firm can hold price; a commodity firm must follow the market down.
• Margin stability across the cycle. A specialty business shows gross margins that stay in a tight band when input costs and volumes swing. A commodity business shows margins that move with raw-material prices — the tell that it is passing through, not adding, value.
• Customer switching costs. If a customer has qualified a product into a regulated formulation, a safety-critical assembly, or a validated process, switching means re-testing and re-approval. High switching costs are among the most durable sources of pricing power there is.
• R&D and IP intensity. Sustained spending on research, plus patents, proprietary process know-how, or regulatory approvals, is what funds and protects differentiation. Commodity businesses compete on scale and cost, and their R&D lines show it.
• Order visibility. Long-term contracts, design-ins, and a firm order book give a specialty business forward visibility a spot-market commodity seller simply does not have. Visibility is both a symptom of stickiness and a source of it.

The unifying test is behaviour under stress. When an input-cost shock or a demand air-pocket arrives, a specialty business’s margins and prices barely flinch, while a commodity business’s swing hard. Stress is the honest examiner; a calm annual report is not.

How does a commodity firm climb to specialty?

A commodity firm climbs to specialty by deliberately building the sources of pricing power it lacks, and the climb is visible in what it funds long before it is visible in its margins. The common routes are moving from bulk output to differentiated grades, from a single input to a formulated system, from an unbranded part to a qualified component inside a customer’s product, or from selling a product to selling a validated, hard-to-replace service around it. Each route adds switching costs, IP, or approvals — the machinery of a price-maker.

What makes the climb real rather than rhetorical is investment and evidence: capacity funded for higher-value grades, R&D that produces protected products, customers who qualify the output into their own regulated processes, and contracts that lengthen. A climb that shows up only in the language of the annual report, with no funded capacity, no new approvals, and no change in margin behaviour, is a story, not a transition. Distinguishing the two is precisely the work.

The buyer decides who is a specialty producer, one purchase order at a time. The company only gets to decide whether to try.

Why a specialty label isn’t the same as specialty economics

The investor’s warning is simple and easy to forget: a specialty label is not the same as specialty economics. Plenty of companies describe themselves as specialty producers while their financials behave exactly like a commodity business — gross margins that rise and fall with raw-material prices, no evidence of switching costs, and pricing that follows the market rather than leading it. The word appears in the investor deck; the economics never arrive.

The discipline that guards against this is to ignore the label and interrogate the behaviour. Do margins hold when inputs spike? Can the firm raise price without losing volume? Are customers locked in by qualification or contract? Is differentiation actually funded by R&D and protected by IP? A business earns the specialty description only when the numbers and revealed behaviour say so under pressure — which is why we trace each of these claims to a dated primary source rather than taking the description at face value. The method page sets out how that evidence is assembled and audited.

Examples in this essay are generic and illustrative of the concept only; they are not observations about any specific company.